Costa Rica vs Montenegro: Access to anti-retroviral drugs, female
Costa Rica
65.0%
in 2024
Montenegro
65.0%
in 2024
Costa Rica rank
91st
Montenegro rank
91st
Access to anti-retroviral drugs, female over time
- Costa Rica
- Montenegro
How they compare
Costa Rica currently reports 65.0% against 65.0% in Montenegro, a difference of 0.0%.
The two have swapped places 6 times across 25 shared years of data; in 2000 it was Montenegro ahead.
Costa Rica ranks 91st and Montenegro ranks 91st of 141 countries.
Costa Rica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Montenegro | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 26.5% | 19.9% | 6.6% | Costa Rica |
| 2010s | 43.0% | 33.0% | 10.0% | Costa Rica |
| 2020s | 60.2% | 50.4% | 9.8% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Costa Rica or Montenegro?
- Costa Rica, at 65.0% against 65.0% in Montenegro as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Costa Rica and Montenegro?
- 0.0%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Montenegro?
- 25 years are reported by both, from 2000 to 2024.
- How do Costa Rica and Montenegro rank globally for access to anti-retroviral drugs, female?
- Costa Rica ranks 91st and Montenegro ranks 91st of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.